Project Grant R01MH140013
Award Date
8/1/25
Completion Date
5/31/30
Dollars Obligated
$845K
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
The National Institute of Mental Health (NIMH) awarded a $1,217,886 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The Feinstein Institutes for Medical Research. The goal of this 5-year project, starting on September 5, 2024, is to develop a clozapine decision support tool for first episode psychosis (FEP) patients. The tool will leverage three biomarkers - a functional brain scan, and genetic tests for weight gain and agranulocytosis risk - to predict which FEP...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $961,668 to The Feinstein Institutes for Medical Research to leverage electronic health records, dimensional phenotyping, and genetic analyses to build predictive models and identify subtypes of clinical outcomes for individuals with schizophrenia and other psychosis-related disorders. The 5-year project aims to advance precision psychiatry by...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), is focused on leveraging electronic health records (EHRs) and genetic data to develop predictive models and identify subtypes of psychosis-related disorders. The key products and services to be delivered under this $1,424,534 award include: Building machine learning-based prediction models to forecast clinical outcomes such as treatment response, illness...
This federal Project Grant award, funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), will support a research project titled "EARLY-PHASE PSYCHOSIS: PRACTICE-BASED RESEARCH TO IMPROVE TREATMENT OUTCOMES". The $1,659,568 award, effective June 2, 2025 through May 31, 2030, will enable the awardee, The Feinstein Institutes for Medical Research, to enroll an additional 625 participants from 13 clinics across 6 states in...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $720,375 to New York University School of Medicine to leverage electronic health records (EHRs) and advanced data analytics to develop predictive models and identify clinical outcome subtypes for psychosis-related disorders. The key products and services to be delivered include: Building machine learning models to forecast major prognostic outcomes...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $779,000 to the University of Chicago to leverage electronic health records, dimensional phenotyping, and genetic analyses to develop machine learning-based predictive models and identify subtypes of clinical outcomes among individuals with schizophrenia. The award aims to advance the goals of precision psychiatry by enabling individualized...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) is funding a $423,500 research project conducted by the University of Rochester. The project aims to derive electroencephalogram (EEG) responses from the early stages of the human visual cortex to study predictive processing in schizophrenia. Specifically, the researchers will use innovative visual stimuli and experiments to measure "perceptual...
The National Institute of Mental Health (NIMH) awarded a $904,100 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the Lovelace Biomedical Research Institute in Albuquerque, New Mexico. The grant, awarded on May 5, 2025, will fund a longitudinal study to develop algorithms that predict mental health functioning and related outcomes, such as recidivism and substance use relapse, in incarcerated women. The research will utilize multimodal data, including psychosocial,...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $434,421 to The Feinstein Institutes for Medical Research to conduct research on the development of cerebellar-cortical functional connectivity in youth and its prediction of psychosis. The key objectives of this 4-year project are to: 1) chart the normal development curves of cerebellar-cortical connectivity from childhood to early adulthood using...
This Project Grant award of $334,588 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) is focused on harnessing collective intelligence to predict clinical outcomes for individuals at high risk of developing psychosis. The key objectives are to: 1) Evaluate the predictive accuracy of a group of psychiatrists using clinical data individually and as a collective intelligence group, and 2) Assess the predictive performance of a...